Evidence map›Paper›PMID 41361119›Full record

ArticleArchives of toxicology2026

Pheochromocytoma in rats: a weak link in the assessment of talc carcinogenicity?

Andrey A Korchevskiy

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Andrey A KorchevskiyChemistry & Industrial Hygiene, Inc., Lakewood, CO, USA. akorchevskiy@c-ih.com.ORCID 0000-0003-0456-3823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This Letter to the Editor addresses the recent step by the International Agency for Research on Cancer (IARC) to reclassify pure talc from Group 2B "Possibly carcinogenic to humans" to Group 2A "Probably carcinogenic to humans". This change was made by IARC not based on any new data, but by reassessing previous studies, including an inhalation study on rats and mice performed in the 1980s under the auspices of the National Toxicology Program (NTP). The NTP study, however, found evidence of tumorigenicity in rats only, but not in mice. This contradicts the toxicological principle of "at least two species" for extrapolating carcinogenicity status from animals to humans. Benign and malignant pheochromocytoma, a rare condition identified in the adrenal medulla of rats in multiple NTP studies, played a special role in the IARC talc reclassification, being evaluated as the "unusual" finding requiring a precautionary approach. The Letter argues that combined benign, malignant, and complex pheochromocytoma in rats is irrelevant for the assessment of talc carcinogenicity in humans. However, with the exclusion of pheochromocytoma argumentation, the need for talc reclassification appears to be highly questionable.

Indexed as

Adrenal Gland NeoplasmsCarcinogensPheochromocytomaTalcAnimalsCarcinogenicity TestsHumansMiceRatsSpecies SpecificityCarcinogensTalcAdrenal medullaCarcinogenicityIARCLung dust overloadPheochromocytomaTalc

Identifiers

PMID41361119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.